Please assess the completion status of the following clinical trial:

Trial Title: PLUTO: Pediatric Lipid-redUction Trial of rOsuvastatin

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 5.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female (at least 1 year post-menarche) children and adolescents (aged 10 -17 years) with heterozygous familial hypercholesterolemia (HeFH)~Exclusion Criteria:~* Certain medical conditions and lab test results~* History of a reaction to rosuvastatin or other statin drugs~* Use of specified disallowed medications

- Gender: ALL
- Minimum Age: 10 Years
- Maximum Age: 17 Years
- Healthy Volunteers: f

Study Arms:
- rosuva 5 (Type: ACTIVE_COMPARATOR): rosuvastatin 5 mg
- rosuva 10 (Type: ACTIVE_COMPARATOR): rosuvastatin 10 mg
- rosuva 20 (Type: ACTIVE_COMPARATOR): rosuvastatin 20 mg
- Placebo (Type: PLACEBO_COMPARATOR): Placebo
- rosuva ol (Type: OTHER): rosuvastatin open label

Based on this trial design, predict the completion outcome and termination type (if applicable).